A new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has today become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. The drug, Lynparza, has been granted Marketing Authorisation from the European Commission.

Crocodiles have pearls in their ears; statues move and speak. The first English translation of a collection of Arab fantasy stories opens a window on to the imaginings of the medieval mind. Professor Malcolm Lyons has brought alive for the modern reader the gripping yarns in Tales of the Marvellous and News of the Strange.